UCEF IV

Predictimmune

, ,

We are delighted to announce that the University of Cambridge Enterprise Fund IV and the Parkwalk Opportunities Fund have closed an investment in Predictimmune Limited, a spinout company from the University of Cambridge. Predictimmune is developing prognostic tests for immune-mediated conditions to aid their management and improve patient outcomes.

Their first offering, PredictImmune-CD, will be […]

Focal Point Positioning

The University of Cambridge Enterprise Fund IV has invested in Focal Point Positioning Limited, a spin-out from the University of Cambridge.
Focal Point has developed software which offers highly accurate positioning of smartphones both indoors and outdoors in urban areas.
The company was founded in June 2015 with Dr Ramsey Faragher as CEO and CTO. The team […]

Polypharmakos

Cambridge and Kew join forces to find new antimicrobial substances in plants
The Parkwalk-mamanged University of Cambridge Enterprise Fund IV and Cambridge Enterprise have invested £500k in Polypharmakos Limited, a spin-out from the University of Cambridge and the Royal Botanic Gardens, Kew.
Polypharmakos’s mission is to screen natural-product sources of plant, fungal and insect origin for […]

PervasID

PervasID  is developing a high reliability, wide area passive RFID system with the potential to provide location capability based on the EPC Class1 Gen2 standard.

Spun out from research activity in the Engineering Department at the University of Cambridge, the technology is now successfully deployed in several field trials.

PsyOmics

PsyOmics  is a University of Cambridge spin-out working to improve the prevention, diagnosis and treatment of neuropsychiatric disorders.

Mental illness accounts for over 15% of the disease burden in developed countries and in England alone, mental illness costs over £51.6bn per annum.

PsyOmics aims to deliver blood based biomarker diagnostics to:

Rapidly diagnose key mental health disorders
[…]

Cambridge Touch Technologies

, ,

Cambridge Touch Technologies (CTT) is a University of Cambridge start-up developing next-gen 3D touch technology.

CTT’s next generation 3D touch technology enables mobile devices to sense both the location and force of multi-touch inputs. CTT’s technology improves on the first generation of 3D technologies recently introduced to mass markets, which allow users to press a […]

Cytora

, , ,

Founded in early 2013, Cytora has built an event detection technology that can detect factual, real world events in unstructured text. The technology can be scaled to cover all major event categories and be monetised across the Financial Services, Defence and Supply Chain markets.

Extracting real world events from unstructured text also provides data for […]

Fluidic Analytics

, , ,

Fluidic Analytics is developing a line of tools for the rapid, accurate, cost-effective analysis of proteins and other biomolecular species. By combining a powerful microfluidics platform

DefiniGEN

, , ,

DefiniGEN provides human cells to the drug discovery sector for use in lead optimization and toxicity programmes.